The Bio Report

Overcoming Resistance to Targeted Therapies

10.25.2023 - By Levine Media GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Stacy Blain, co-founder and chief scientific officer of Concarlo, discusses the development of drug resistance in cancer, the company’s initial focus on breast cancer, and her own journey from academia to biopharma.

More episodes from The Bio Report